I have a patent pending for “deuteron therapy” (DT). DT has over 80% less straggling than proton therapy, probably identical radiobiological properties, and could be implemented alongside a proton beam in the same cyclotron.

Do you think there might be a role for DT in Tx of ocular cancers?

More Robert Zamenhof's questions See All
Similar questions and discussions